Works matching IS 17528054 AND DT 2023 AND VI 16 AND IP 12
Results: 34
Vericiguat, a novel sGC stimulator: Mechanism of action, clinical, and translational science.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2458, doi. 10.1111/cts.13677
- By:
- Publication type:
- Article
Pharmacokinetic/LDL‐C and exposure–response analysis of tafolecimab in Chinese hypercholesterolemia patients: Results from phase I, II, and III studies.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2791, doi. 10.1111/cts.13674
- By:
- Publication type:
- Article
Effect of collateral circulation in patients with multiple craniocervical artery stenoses.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2779, doi. 10.1111/cts.13673
- By:
- Publication type:
- Article
Leukocyte cell‐derived chemotaxin 2 correlates with pediatric non‐alcoholic fatty liver disease.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2719, doi. 10.1111/cts.13666
- By:
- Publication type:
- Article
Neutrophil elastase activates the release of extracellular traps from COPD blood monocyte‐derived macrophages.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2765, doi. 10.1111/cts.13671
- By:
- Publication type:
- Article
Global harmonization of immediate‐release solid oral drug product bioequivalence recommendations and the impact on generic drug development.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2756, doi. 10.1111/cts.13670
- By:
- Publication type:
- Article
Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2744, doi. 10.1111/cts.13669
- By:
- Publication type:
- Article
Free heme and hemopexin in acute kidney injury after cardiopulmonary bypass and transient renal ischemia.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2729, doi. 10.1111/cts.13667
- By:
- Publication type:
- Article
Healthcare professionals' and consumers' knowledge, attitudes, perspectives, and education needs in oncology pharmacogenomics: A systematic review.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2467, doi. 10.1111/cts.13672
- By:
- Publication type:
- Article
A randomized, controlled trial of prulifloxacin as conversion therapy after intravenous carbapenem in the treatment of acute pyelonephritis caused by third generation cephalosporin resistant pathogens: A pilot study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2709, doi. 10.1111/cts.13665
- By:
- Publication type:
- Article
Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2700, doi. 10.1111/cts.13664
- By:
- Publication type:
- Article
Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID‐19 patients with pre‐existing comorbidities.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2687, doi. 10.1111/cts.13663
- By:
- Publication type:
- Article
Phase I crossover study of DNA‐protein kinase inhibitor peposertib in healthy volunteers: Effect of food and pharmacokinetics of an oral suspension.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2628, doi. 10.1111/cts.13657
- By:
- Publication type:
- Article
Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2675, doi. 10.1111/cts.13662
- By:
- Publication type:
- Article
Rademikibart (CBP‐201), a next‐generation monoclonal antibody targeting human IL‐4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitis.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2614, doi. 10.1111/cts.13656
- By:
- Publication type:
- Article
Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register data.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2654, doi. 10.1111/cts.13659
- By:
- Publication type:
- Article
Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2640, doi. 10.1111/cts.13658
- By:
- Publication type:
- Article
Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2483, doi. 10.1111/cts.13661
- By:
- Publication type:
- Article
Trends in oncology drug lags in Japan from 2001 to 2020: A cross‐sectional study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2665, doi. 10.1111/cts.13660
- By:
- Publication type:
- Article
Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2421, doi. 10.1111/cts.13655
- By:
- Publication type:
- Article
A first‐in‐human phase I study of SHR‐1906, a humanized monoclonal antibody against connective tissue growth factor, in healthy participants.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2604, doi. 10.1111/cts.13654
- By:
- Publication type:
- Article
Lidocaine as an anti‐arrhythmic drug: Are there any indications left?
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2429, doi. 10.1111/cts.13650
- By:
- Publication type:
- Article
Bioequivalence study of dacomitinib and Vizimpro® in healthy Chinese volunteers under fasting and fed conditions: A randomized, open‐label, single‐dose, crossover trial.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2591, doi. 10.1111/cts.13653
- By:
- Publication type:
- Article
Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolism.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2438, doi. 10.1111/cts.13652
- By:
- Publication type:
- Article
The presence of busulfan metabolites and pharmacometabolomics in plasma drawn immediately before allograft infusion in hematopoietic cell transplant recipients.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2577, doi. 10.1111/cts.13651
- By:
- Publication type:
- Article
Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2519, doi. 10.1111/cts.13642
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2413, doi. 10.1111/cts.13331
- Publication type:
- Article
Prevalence and prescribing patterns of oral corticosteroids in the United States, Taiwan, and Denmark, 2009–2018.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2565, doi. 10.1111/cts.13649
- By:
- Publication type:
- Article
Applying Natural Language Processing to ClinicalTrials.gov: mRNA cancer vaccine case study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2417, doi. 10.1111/cts.13648
- By:
- Publication type:
- Article
The use of microtracers in food‐effect trials: An alternative study design for toxic drugs with long half‐lives exemplified by the case for alectinib.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2557, doi. 10.1111/cts.13647
- By:
- Publication type:
- Article
Effect of vitamin D supplementation on circulating level of autophagosome protein LC3A, inflammation, and physical performance in knee osteoarthritis.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2543, doi. 10.1111/cts.13646
- By:
- Publication type:
- Article
uConsent: Addressing the gap in measuring understanding of informed consent in clinical research.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2530, doi. 10.1111/cts.13645
- By:
- Publication type:
- Article
Factors influencing new‐onset hypertension in elderly patients with obstructive sleep apnea: A multicenter cohort study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2507, doi. 10.1111/cts.13631
- By:
- Publication type:
- Article
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2494, doi. 10.1111/cts.13624
- By:
- Publication type:
- Article